Mallinckrodt Explores Repeat Bankruptcy as $200 Million Opioid Payment Comes Due
Wall Street Journal
The generic drugmaker is facing financial headwinds after emerging from chapter 11 last year with a settlement plan to pay opioid victims.
Understanding current events through the lenses of the past and future.
Wall Street Journal
The generic drugmaker is facing financial headwinds after emerging from chapter 11 last year with a settlement plan to pay opioid victims.